New Launch: Hetero launches – Tafero-EM – FDC combo of ‘emtricitabine & tenofovir alafenamide’ in India
Hetero, one of India’s leading generic pharmaceutical companies and world’s largest producer of anti-retroviral drugs, announced the launch of the first generic... Read More
Case Study: Lilly’ US FDA approval of Verzenio in combination with aromatase inhibitor to treat advanced breast cancer
Eli Lilly and Company has announced that the US Food and Drug Administration (FDA) has approved Verzenio (abemaciclib) in combination with an... Read More
Cipla – Roche Deal – Cipla will promote and distribute Roche’s tocilizumab and Syndyma in India
Cipla Ltd and Roche Pharma India has entered an agreement under which Cipla will promote and distribute tocilizumab and Syndyma, the 2nd... Read More
AstraZeneca launches once-daily Xigduo XR tablets for comprehensive management of type 2 diabetes in India
AstraZeneca Pharma India Limited (AstraZeneca India) has announced the launch of its innovative anti-diabetic combination once-daily therapy Xigduo XR for treatment of... Read More
MSD’s verubecestat fails in Phase 3 Alzheimer’s trial
US pharma giant Merck & Co has halted a Phase III trial of verubecestat (MK-8931) in people with prodromal Alzheimer’s disease (AD)... Read More
Astellas to acquire Universal Cells for up to $102.5M
Astellas Pharma has acquired Seattle, WA-based Universal Cells, Inc. and its Universal Donor Cell technology enabling the creation of cell therapy products... Read More